Ines Kobor

Modeling and bioinformatics identify responders to G-CSF in patients with amyotrophic lateral sclerosis

Combinatory Biomarker Use of Cortical Thickness, MUNIX, and ALSFRS-R at Baseline and in Longitudinal Courses of Individual Patients With Amyotrophic Lateral Sclerosis

Long-term Outcome of Filgrastim (G-CSF) in ALS Patients (P4.457)

Longitudinal Diffusion Tensor Imaging-Based Assessment of Tract Alterations: An Application to Amyotrophic Lateral Sclerosis

PB 1 In vivo assessment of neurodegeneration in the brain by serial longitudinal diffusion tensor imaging – an application to amyotrophic lateral sclerosis

Approach towards an ALS-specific structural marker of motor tract integrity for the description of different ALS progression types using diffusion-weighted imaging (S53.003)

Safety, Tolerability and Monitoring of Long-Term G-CSF Compassionate Use in ALS Patients (P3.181)

Very Longterm MRI Data May Show Individual Disease Progression in Amyotrophic Lateral Sclerosis (ALS) Patients Treated with Granulocyte Colony Stimulating Factor (G-CSF) (P4.098)

MUNIX – ein viel versprechender Biomarker bei der ALS

Safety and Feasibility of G-CSF Compassionate use in ALS Patients (P6.009)

Can MRI-Biomarker prove stabilization in G-CSF-treated ALS patients?

Biomarker - Discovery in G-CSF mediated clinical ALS Stabilization (P6.005)

“Reporting biomarker” development: Update in als patients treated with G-CSF -mobilized hematopoietic stem cells